• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W. L. GORE & ASSOCIATES, INC. GORE® VIABAHN® ENDOPROSTHESIS WITH HEPARIN BIOACTIVE SURFACE; STENT, SUPERFICIAL FEMORAL ARTERY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W. L. GORE & ASSOCIATES, INC. GORE® VIABAHN® ENDOPROSTHESIS WITH HEPARIN BIOACTIVE SURFACE; STENT, SUPERFICIAL FEMORAL ARTERY Back to Search Results
Catalog Number VBJR050502A
Device Problems Leak/Splash (1354); Patient Device Interaction Problem (4001)
Patient Problems Aneurysm (1708); Hemorrhage/Bleeding (1888)
Event Date 03/08/2021
Event Type  Injury  
Manufacturer Narrative
Cbas® heparin surface incorporates cbas-heparin manufactured from heparin sodium api, which is covalently bound to the device surface and is essentially non-eluting.
 
Event Description
The following information was reported to gore: in an article titled "outcomes of endovascular repair of chronic post dissection compared with degenerative thoracoabdominal aortic aneurysms using fenestrated-branched stent grafts".Objective: the objective of this study was to analyze outcomes of fenestrated-branched endovascular aneurysm repair (f/bevar) for treatment of postdissection and degenerative thoracoabdominal aortic aneurysms (taaas).Methods: we reviewed the clinical data of 240 patients with extent i to extent iii taaas enrolled in seven prospective physician-sponsored investigational device exemption studies from 2014 to 2017.All patients had manufactured off-the-shelf or patient-specific fenestrated-branched stent grafts used to target 888 renal-mesenteric arteries with a mean of 3.7 vessels per patient.The article notes: type ic and iiic endoleaks that occurred which could potentially be associated with the gore® viabahn® endoprosthesis with heparin bioactive surface devices implanted.
 
Manufacturer Narrative
Added a1 (3551).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE® VIABAHN® ENDOPROSTHESIS WITH HEPARIN BIOACTIVE SURFACE
Type of Device
STENT, SUPERFICIAL FEMORAL ARTERY
Manufacturer (Section D)
W. L. GORE & ASSOCIATES, INC.
1505 n. fourth street
flagstaff AZ 86004
Manufacturer (Section G)
MEDICAL ECHO RIDGE B/P
3250 w. kiltie lane
flagstaff AZ 86005
Manufacturer Contact
marcos ayala
1505 n. fourth street
flagstaff, AZ 86004
9285263030
MDR Report Key11625293
MDR Text Key244163751
Report Number2017233-2021-01847
Device Sequence Number1
Product Code NIP
Combination Product (y/n)Y
Reporter Country CodeUS
PMA/PMN Number
P040037
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 12/29/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberVBJR050502A
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 03/17/2021
Initial Date FDA Received04/06/2021
Supplement Dates Manufacturer Received03/17/2021
03/17/2021
Supplement Dates FDA Received12/29/2021
12/29/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient SexMale
-
-